Replies to post #1870390 on MOMO'S BREAKOUT BOARD

[ClairvoyantTrader]

?$AMLH is next Esports

[BERKSHIRE AGENT]

SOAN HUGE PATENT NEWS!!! SOAN AngioSoma, Inc. Announces Grant of Patent for Flagship Drug
May 14, 2018 News Tags: AngioSoma Inc., AngioSoma Inc. News, SOAN, SOAN News
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship pharmaceutical, Liprostin™ that is intended to treat Peripheral Artery Disease, or PAD.

We are told the market opportunity is significant with 8 million U.S. diagnosed cases of PAD costing $212 - $389 billion annually. PAD costs exceed diabetes, coronary artery disease and cancers. It is reported that 60% to 70% of diabetics contract peripheral artery disease, often resulting in amputation as treatment.

Clinical Trials I, and II a-b-c have shown that Liprostin™ is effective for treating walking pain and circulation. However, the third clinical trial must be successfully completed before Liprostin™ may be commercialized.